![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/513 | |
A61K 9/127 | |||
A61K 31/282 | |||
A61K 31/4412 | |||
A61K 31/53 | |||
A61K 47/24 | |||
A61K 47/34 | |||
A61P 35/00 | |||
A61P 43/00 |
(11) | Patento numeris | 2246056 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09706367.1 |
Europos patento paraiškos padavimo data | 2009-01-29 | |
(97) | Europos patento paraiškos paskelbimo data | 2010-11-03 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-27 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/JP2009/051499 |
Data | 2009-01-29 |
(87) | Numeris | WO 2009/096487 |
Data | 2009-08-06 |
(30) | Numeris | Data | Šalis |
2008019141 | 2008-01-30 | JP | |
2008306072 | 2008-12-01 | JP |
(72) |
ISHIDA, Tatsuhiro, JP
KIWADA, Hiroshi, JP
|
(73) |
Taiho Pharmaceutical Co., Ltd.,
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444,
JP
The University of Tokushima, 24, Shinkura-cho 2-chome, Tokushima-shi, Tokushima 770-8501, JP |
(54) | AGENT FOR ENHANCING ANTI-TUMOR EFFECT COMPRISING OXALIPLATIN LIPOSOME PREPARATION, AND ANTI-TUMOR AGENT COMPRISING THE LIPOSOME PREPARATION |
AGENT FOR ENHANCING ANTI-TUMOR EFFECT COMPRISING OXALIPLATIN LIPOSOME PREPARATION, AND ANTI-TUMOR AGENT COMPRISING THE LIPOSOME PREPARATION |